share_log

EF Hutton Assumes Ocean Biomedical at Buy, Announces Price Target of $17

EF Hutton Assumes Ocean Biomedical at Buy, Announces Price Target of $17

EF Hutton假设海洋生物医学处于买入状态,宣布目标股价为17美元
Benzinga ·  2023/05/25 07:16

EF Hutton analyst Tony Butler assumes Ocean Biomedical (NASDAQ:OCEA) with a Buy rating and announces Price Target of $17.

EF Hutton分析师托尼·巴特勒假设海洋生物医学(纳斯达克股票代码:OCEA)的评级为买入,并宣布目标股价为17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发